Ifp Advisors, Inc Astrazeneca PLC Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Ifp Advisors, Inc holds 5,726 shares of AZN stock, worth $361,883. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,726

Previous 4,660 22.88%

Holding current value

$361,883

Previous $315,000 41.59%

% of portfolio

0.02%

Previous 0.01%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$66.81 - $80.83 $71,219 - $86,164	1,066 Added 22.88%	5,726 $446,000
Q1 2024 Jul 30, 2024	SELL	$61.03 - $69.57 $16,661 - $18,992	-273 Reduced 5.53%	4,660 $315,000
Q4 2023 Jan 09, 2024	SELL	$61.89 - $69.28 $58,114 - $65,053	-939 Reduced 15.99%	4,933 $332,000
Q3 2023 Oct 12, 2023	BUY	$64.85 - $71.7 $74,188 - $82,024	1,144 Added 24.2%	5,872 $397,000
Q2 2023 Aug 04, 2023	SELL	$69.91 - $75.81 $33,626 - $36,464	-481 Reduced 9.23%	4,728 $338,000
Q1 2023 Apr 18, 2023	SELL	$63.15 - $71.6 $549,089 - $622,562	-8,695 Reduced 62.54%	5,209 $361,000
Q4 2022 Feb 07, 2023	BUY	$54.21 - $70.44 $220,417 - $286,409	4,066 Added 41.33%	13,904 $527,000
Q3 2022 Nov 08, 2022	BUY	$53.02 - $135.75 $99,465 - $254,667	1,876 Added 23.56%	9,838 $381,000
Q2 2022 Sep 06, 2022	BUY	$59.26 - $71.14 $471,828 - $566,416	7,962 New	7,962 $307,000
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $471,828 - $566,416	-7,962 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$55.72 - $67.12 $268,904 - $323,921	4,826 Added 153.89%	7,962 $528,000
Q1 2022 Aug 08, 2022	BUY	$55.72 - $67.12 $9,862 - $11,880	177 Added 5.98%	3,136 $208,000
Q4 2021 Jan 12, 2022	SELL	$54.02 - $63.83 $7,184 - $8,489	-133 Reduced 4.3%	2,959 $175,000
Q3 2021 Oct 06, 2021	SELL	$55.56 - $60.79 $33,613 - $36,777	-605 Reduced 16.36%	3,092 $187,000
Q2 2021 Jul 13, 2021	SELL	$48.42 - $60.18 $75,680 - $94,061	-1,563 Reduced 29.71%	3,697 $223,000
Q1 2021 Apr 30, 2021	SELL	$47.16 - $54.44 $81,869 - $94,507	-1,736 Reduced 24.81%	5,260 $261,000
Q4 2020 Jan 25, 2021	BUY	$48.52 - $58.02 $32,168 - $38,467	663 Added 10.47%	6,996 $345,000
Q3 2020 Oct 29, 2020	BUY	$53.07 - $61.1 $146,048 - $168,147	2,752 Added 76.85%	6,333 $348,000
Q2 2020 Aug 05, 2020	BUY	$43.1 - $55.31 $12,283 - $15,763	285 Added 8.65%	3,581 $190,000
Q1 2020 May 12, 2020	SELL	$37.79 - $51.33 $4,988 - $6,775	-132 Reduced 3.85%	3,296 $139,000
Q4 2019 Jan 17, 2020	SELL	$42.46 - $50.46 $28,957 - $34,413	-682 Reduced 16.59%	3,428 $172,000
Q3 2019 Nov 07, 2019	BUY	$40.12 - $45.47 $110,129 - $124,815	2,745 Added 201.1%	4,110 $184,000
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $211,378 - $256,227	-5,956 Reduced 81.36%	1,365 $54,000
Q4 2018 Jan 23, 2019	SELL	$36.86 - $41.49 $39,845 - $44,850	-1,081 Reduced 12.87%	7,321 $278,000
Q3 2018 Oct 25, 2018	BUY	$34.76 - $39.72 $764 - $873	22 Added 0.26%	8,402 $0
Q2 2018 Aug 07, 2018	SELL	$34.55 - $37.05 $29,574 - $31,714	-856 Reduced 9.27%	8,380 $0
Q1 2018 Jun 03, 2019	SELL	$32.97 - $36.63 $15,561 - $17,289	-472 Reduced 4.86%	9,236 $320,000
Q1 2018 May 09, 2018	BUY	$32.97 - $36.63 $15,561 - $17,289	472 Added 5.11%	9,708 $0
Q4 2017 Jan 24, 2018	SELL	$32.09 - $34.78 $215,548 - $233,617	-6,717 Reduced 42.1%	9,236 $0
Q3 2017 Oct 30, 2017	BUY	$28.96 - $34.0 $40,051 - $47,022	1,383 Added 9.49%	15,953 $540,000
Q2 2017 Jun 03, 2019	BUY	N/A	3,235 Added 28.54%	14,570 $497,000
Q1 2017 Jun 03, 2019	BUY	N/A	2,491 Added 28.17%	11,335 $353,000
Q4 2016 Jun 03, 2019	SELL	N/A	-9,808 Reduced 52.58%	8,844 $242,000
Q2 2016 Jun 03, 2019	BUY	N/A	17,287 Added 1266.45%	18,652 $563,000
Q1 2016 Jun 03, 2019	BUY	N/A	1,365	1,365 $54,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $196B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account